Tina Woods, Nic Palmarini, Lynne Corner, et al. Cities, communities and clinics can be testbeds for human exposome and aging research. Nature Medicine. 2025:1-3. doi:10.1038/s41591-025-03519-8
Zehra Yildirim, Kyle Swanson, Xuekun Wu, James Zou, Joseph Wu. Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish. Annual Review of Pharmacology and Toxicology. 2025;65(Volume 65, 2025):71-90. doi:10.1146/annurev-pharmtox-022724-095035
Monique M. A. Verstegen, Rob P. Coppes, Anne Beghin, et al. Clinical applications of human organoids. Nature Medicine. 2025:1-13. doi:10.1038/s41591-024-03489-3
Surat Parvatam, Francesca Pistollato, Lindsay J. Marshall, et al. Human-based complex in vitro models: their promise and potential for rare disease therapeutics. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1526306
Daisong Wang, Remi Villenave, Nadine Stokar-Regenscheit, Hans Clevers. Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges. Nature Reviews Drug Discovery. 2025:1-23. doi:10.1038/s41573-025-01317-y
Derrick Butler, Darwin R. Reyes. Heart-on-a-chip systems: disease modeling and drug screening applications. Lab on a Chip. 2024;24(5):1494-1528. doi:10.1039/D3LC00829K
Mauricio Goncalves da Costa Sousa, Sofia M. Vignolo, Cristiane Miranda Franca, et al. Engineering models of head and neck and oral cancers on-a-chip. Biomicrofluidics. 2024;18:021502. doi:10.1063/5.0186722
Caitlin Lynch, Srilatha Sakamuru, Masato Ooka, et al. High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions. Annual Review of Pharmacology and Toxicology. 2024;64(Volume 64, 2024):191-209. doi:10.1146/annurev-pharmtox-112122-104310